OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...
On Thursday, OpenAI announced it had developed a large language model specifically trained on common biology workflows.
Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner Neurocrine Biosciences Inc. (“Neurocrine”) has initiated and dosed the first patient (s) in a Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results